StockData
Koninklijke Philips NV logo

Koninklijke Philips NV (RYLPF) stock analysis

RYLPFOTCX-Ray Apparatus & Tubes & Related Irradiation ApparatusFiscal year ends December 31Also trades as PHG
Financials through fiscal 2024, year ended Dec 31, 2025Last filing: 20-F on Feb 19, 2026Score 5/30
$25.86+0.43 (+1.69%)

Close on Oct 19, 2026Market cap $24.90BP/E 24.9Yield –

StockData Score

Prices as of Nov 4, 2026How the score works

Value0Growth1Performance3Health1Dividend0

Weak5 of 30 checks passed

Koninklijke Philips passes 5 of the 30 checks behind our score; 16 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
0/6
Growth
1/6
Past performance
3/6
Financial health
1/6
Dividend
0/6

What stands out

  • Gross margin improving

    Gross margin was 45.2% over the last twelve months, against 43.1% a year earlier.

  • Return on equity above the industry

    Koninklijke Philips's return on equity of 7.8% is above the Surgical, Medical, and Dental Instruments and Supplies median of -35.0%.

  • Net margin above its 5-year average

    Net margin was 5.0% over the last twelve months, against a 5-year average of 1.8%.

  • Net margin above the industry

    Koninklijke Philips's net margin of 5.0% is above the Surgical, Medical, and Dental Instruments and Supplies median of -14.9%.

What to watch

  • Return on equity under 15%

    Return on equity was 7.8% over the last twelve months and averaged 2.4% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 6.5%, below the 10% that usually covers the cost of capital.

  • High debt

    Debt is 73.8% of shareholders' equity, above the 40% we consider low.

  • Earnings shrank over 5 years

    Net income shrank 5.5% a year on average over the last five fiscal years.

Valuation0/6

  • P/E against its history

    Not enough price and earnings history to compare.

  • P/E against the industry

    Needs positive earnings and enough profitable companies in the industry.

  • EV/EBITDA against its history

    Needs positive EBITDA and price history.

  • P/B against the industry

    Needs positive book value.

  • Price against fair value

    We could not estimate a fair value: it needs at least two valuation methods with positive inputs.

  • Margin of safety

    Depends on the fair value estimate.

Growth1/6

  • Revenue growing under 10% a year

    Revenue grew 0.0% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growth over 3 years

    Needs positive EPS three years ago and today.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing slower than the industry

    Revenue grew -1.0% over the last twelve months; the Surgical, Medical, and Dental Instruments and Supplies median is 9.8%.

  • Company guidance

    No outlook found in earnings releases from the last twelve months.

  • Gross margin improving

    Gross margin was 45.2% over the last twelve months, against 43.1% a year earlier.

Past performance3/6

  • Return on equity under 15%

    Return on equity was 7.8% over the last twelve months and averaged 2.4% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 6.5%, below the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    Koninklijke Philips's return on equity of 7.8% is above the Surgical, Medical, and Dental Instruments and Supplies median of -35.0%.

  • Earnings shrank over 5 years

    Net income shrank 5.5% a year on average over the last five fiscal years.

  • Net margin above its 5-year average

    Net margin was 5.0% over the last twelve months, against a 5-year average of 1.8%.

  • Net margin above the industry

    Koninklijke Philips's net margin of 5.0% is above the Surgical, Medical, and Dental Instruments and Supplies median of -14.9%.

Financial health1/6

  • High debt

    Debt is 73.8% of shareholders' equity, above the 40% we consider low.

  • Debt rising against equity

    Debt to equity rose from 58.4% five years ago to 73.8%.

  • Debt coverage

    Needs operating cash flow.

  • Interest not well covered

    Operating income covers interest expense 4.1 times; we look for at least 5.

  • Short-term assets cover short-term debts

    Current assets are 1.32 times current liabilities.

  • Bankruptcy risk (Altman Z)

    Needs market value, working capital and retained earnings.

Dividend0/6

  • No dividend

    Koninklijke Philips has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

Fair value

How we estimate it

We don't publish a fair value for Koninklijke Philips. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$32.98M
Value traded per 1% price move
$23.36M

Downside

Low risk

Typical loss in a bad month
14.4%
Volatility (annualized)
29%
Sharpe ratio, 1 year
-0.01
Beta to the S&P 500 (5Y)
0.99

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2013 to 2024

Gross margin

45.2%+0.0 pts over 5 years

Operating margin

8.0%+0.7 pts over 5 years

Net margin

5.0%−1.8 pts over 5 years

See a number that looks wrong?